ProPhase Labs Partners With mProbe, Mayo Clinic on Esophageal Cancer Screening Test
The mass spec-based proteomic assay, which was originally developed by Stella Diagnostics, is designed for the early detection of esophageal cancer.
In Brief This Week: Thermo Fisher Scientific, Leica Biosystems, Genetron, SomaLogic, More
News items for the week of Nov. 7, 2022.
Genomadix, Mayo Clinic Collaborate on Point-of-Care PCR
The deal is intended to advance the firm's portable PCR-based diagnostics system, called the Cube, which generates results in approximately one hour.
Cancer Centers Nudge Oncologists Toward DPYD Testing as PGx Supporters Push For Guidelines Change
Several institutions, swayed by PGx experts and advocates, are setting up DPYD testing to avoid deadly chemo toxicities in patients even though the NCCN and FDA don't back it.
Metabolon, Mayo Clinic Partner to Develop Metabolomic Biomarker Tests
The company will analyze patient samples from Mayo Clinic to look for disease biomarkers and design diagnostic tests.
Jul 24, 2022
Apr 13, 2022
Jun 2, 2021